Inhibrx Biosciences, Inc. Common Stock
Veridion Score
Composite trend over time
Why is INBX moving today?
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for INBX.
INBX insider activity
Inhibrx Biosciences, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for INBX.
INBX contract awards, year to date.
Public federal awards linked to this ticker.
INBX lobbying filings, year to date.
Registered lobbying filings matched to Inhibrx Biosciences, Inc. Common Stock.